'Complete game-changer': Cancer survivors stress importance of bill for testing
Cancer survivors want to see more access to screenings that they call "a game changer." It's called biomarker testing, which analyzes a patient's tissue, blood or other bodily fluids to help pinpoint ...
Cure Today22 小时
Breyanzi Improves Responses in R/R Indolent B-Cell Non-Hodgkin Lymphoma
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.OtgQHJex.js ...
FiercePharma4 天
Bristol Myers angles Breyanzi for another blood cancer as it works to close Gilead's CAR-T lead
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...